Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.

Vidal L, Ben Dor I, Paul M, Eliakim-Raz N, Pokroy E, Soares-Weiser K, Leibovici L.

Cochrane Database Syst Rev. 2013 Oct 9;10:CD003992. doi: 10.1002/14651858.CD003992.pub3. Review.

PMID:
24105485
2.

Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.

Vidal L, Paul M, Ben-Dor I, Pokroy E, Soares-Weiser K, Leibovici L.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003992. Review. Update in: Cochrane Database Syst Rev. 2013;10:CD003992.

PMID:
15495074
3.

Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials.

Vidal L, Paul M, Ben dor I, Soares-Weiser K, Leibovici L.

J Antimicrob Chemother. 2004 Jul;54(1):29-37. Epub 2004 Jun 16. Review.

4.

Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia.

Paul M, Dickstein Y, Schlesinger A, Grozinsky-Glasberg S, Soares-Weiser K, Leibovici L.

Cochrane Database Syst Rev. 2013 Jun 29;6:CD003038. doi: 10.1002/14651858.CD003038.pub2. Review.

PMID:
23813455
5.

Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.

Paul M, Dickstein Y, Borok S, Vidal L, Leibovici L.

Cochrane Database Syst Rev. 2014 Jan 14;1:CD003914. doi: 10.1002/14651858.CD003914.pub3. Review.

PMID:
24425445
6.

Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients.

Paul M, Borok S, Fraser A, Vidal L, Cohen M, Leibovici L.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003914. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD003914.

PMID:
16034915
7.

Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.

van Dalen EC, Mank A, Leclercq E, Mulder RL, Davies M, Kersten MJ, van de Wetering MD.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD006247. doi: 10.1002/14651858.CD006247.pub2. Review.

PMID:
22972091
8.

Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.

Paul M, Soares-Weiser K, Grozinsky S, Leibovici L.

Cochrane Database Syst Rev. 2003;(3):CD003038. Review. Update in: Cochrane Database Syst Rev. 2013;6:CD003038.

PMID:
12917941
9.

Colony-stimulating factors for chemotherapy-induced febrile neutropenia.

Mhaskar R, Clark OA, Lyman G, Engel Ayer Botrel T, Morganti Paladini L, Djulbegovic B.

Cochrane Database Syst Rev. 2014 Oct 30;10:CD003039. doi: 10.1002/14651858.CD003039.pub2. Review.

PMID:
25356786
10.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900
11.

Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections.

Shiu J, Wang E, Tejani AM, Wasdell M.

Cochrane Database Syst Rev. 2013 Mar 28;3:CD008481. doi: 10.1002/14651858.CD008481.pub2. Review.

PMID:
23543565
12.

Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.

Paul M, Soares-Weiser K, Grozinsky S, Leibovici L.

Cochrane Database Syst Rev. 2002;(2):CD003038. Review. Update in: Cochrane Database Syst Rev. 2003;(3):CD003038.

PMID:
12076467
13.

Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.

Gafter-Gvili A, Fraser A, Paul M, Vidal L, Lawrie TA, van de Wetering MD, Kremer LC, Leibovici L.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD004386. doi: 10.1002/14651858.CD004386.pub3. Review.

14.

Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.

Skoetz N, Bohlius J, Engert A, Monsef I, Blank O, Vehreschild JJ.

Cochrane Database Syst Rev. 2015 Dec 21;12:CD007107. doi: 10.1002/14651858.CD007107.pub3. Review.

PMID:
26687844
15.

Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.

Paul M, Lador A, Grozinsky-Glasberg S, Leibovici L.

Cochrane Database Syst Rev. 2014 Jan 7;1:CD003344. doi: 10.1002/14651858.CD003344.pub3. Review.

PMID:
24395715
16.

Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.

Renner P, Milazzo S, Liu JP, Zwahlen M, Birkmann J, Horneber M.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD007913. doi: 10.1002/14651858.CD007913.pub2. Review.

PMID:
23076939
17.

Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.

Gafter-Gvili A, Fraser A, Paul M, van de Wetering M, Kremer L, Leibovici L.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004386. Review. Update in: Cochrane Database Syst Rev. 2012;1:CD004386.

PMID:
16235360
18.

Antibiotics for treating chronic osteomyelitis in adults.

Conterno LO, Turchi MD.

Cochrane Database Syst Rev. 2013 Sep 6;9:CD004439. doi: 10.1002/14651858.CD004439.pub3. Review.

PMID:
24014191
19.

Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.

Loeffen EA, Te Poele EM, Tissing WJ, Boezen HM, de Bont ES.

Cochrane Database Syst Rev. 2016 Feb 22;2:CD008382. doi: 10.1002/14651858.CD008382.pub2. Review.

PMID:
26899263
20.

Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.

Paul M, Yahav D, Bivas A, Fraser A, Leibovici L.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD005197. doi: 10.1002/14651858.CD005197.pub3. Review.

PMID:
21069685
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk